On May 16, 2022 Flamingo Therapeutics, a biotechnology company pioneering RNA-targeting therapies in oncology, reported that Mike Garrett, Chief Executive Officer, will present a company overview at the BioEquity Europe and Knowledge for Growth meetings, taking place May 16-18 in Milan, Italy and May 18-19 in Ghent, Belgium (Press release, Flamingo Therapeutics, MAY 16, 2022, View Source;utm_medium=rss&utm_campaign=flamingo-therapeutics-to-present-at-the-bioequity-europe-and-knowledge-for-growth-conferences-in-may-2022 [SID1234614588]). The Flamingo management team will also participate in one-on-one meetings with investors during both conferences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentations for both conferences will be available on-demand for registered attendees.